The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Cited by (1,000)

Items 801–900 of 1,000

  1. Biology and Treatment of Myeloma
    Annamaria Brioli, Lorenzo Melchor, Brian A. Walker, Faith E. Davies, Gareth John Morgan · 2014 · Clinical Lymphoma Myeloma & Leukemia
  2. Molecular Genetics of Pancreatic Neoplasms
    Waki Hosoda, Laura DeLong Wood · 2016 · Surgical pathology clinics
  3. Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma
    Lili Zhao, Bingrong Liu · 2017 · Oncotarget
  4. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis
    Yusuke Fujita, Sachiko Matsuda, Yasushi Sasaki, Yohei Masugi, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Masahiro Shinoda, Takashi Tokino, Michiie Sakamoto et al. · 2019 · Cancer Science
  5. Treatment optimization of locally advanced and metastatic pancreatic cancer (Review)
    Anabela Barros, Catarina Pulido, Manuela Machado, María José Brito, Nuno Couto, Olga Sousa, Sónia A. Melo, Hélder Mansinho · 2021 · International Journal of Oncology
  6. Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer
    Chuanli Ren, Hui Chen, Chongxu Han, Guangfu Jin, Daxin Wang, Daorong Wang, Dong Tang · 2013 · Medical Hypotheses
  7. Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma
    Wei Jiang, Essel Dulaimi, Karthik Devarajan, Theodore M. Parsons, Qiong Wang, Raymond O’Neill, Charalambos Solomides, Stephen C. Peiper, Joseph R. Testa, Robert G. Uzzo et al. · 2017 · Oncotarget
  8. Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours
    Bernardo Rodríguez–Martín, Eva G. Álvarez, Adrian Baez‐Ortega, Jorge Zamora, Fran Supek, Jonas Demeulemeester, Martín Santamarina, Young Seok Ju, Javier Temes, Daniel García Souto et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Profilin 1 deficiency drives mitotic defects and reduces genome stability
    Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida et al. · 2023 · Communications Biology
  10. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer
    Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, Infancia Lawrence, Arunkumar Radhakrishnan · 2024 · Archives of Microbiology
  11. Research autopsy programmes in oncology: shared experience from 14 centres across the world
    Tatjana Geukens, Marion Maetens, Jody E. Hooper, Steffi Oesterreich, Adrian V. Lee, Lori Miller, Jenny M Atkinson, Margaret Quinn Rosenzweig, Shannon Puhalla, Heather Thorne et al. · 2024 · The Journal of Pathology
  12. Genomics and pharmacogenomics of pancreatic adenocarcinoma
    Maeve Aine Lowery, Eileen Mary O'Reilly · 2011 · The Pharmacogenomics Journal
  13. Perspectives of Integrative Cancer Genomics in Next Generation Sequencing Era
    So Mee Kwon, Hyunwoo Cho, Ji Hye Choi, Byul A Jee, Yuna Jo, Hyun Goo Woo · 2012 · Genomics & Informatics
  14. Tumor antigen discovery through translation of the cancer genome
    Michael Siavash Khodadoust, Ash A. Alizadeh · 2014 · Immunologic Research
  15. Exome‐wide single‐base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse
    Carolyn A. Paisie, Morgan S. Schrock, Jenna R. Karras, Jie Zhang, Satoshi Miuma, Iman M. Ouda, Catherine E. Waters, Joshua C. Saldivar, Teresa Druck, Kay Huebner · 2016 · Cancer Science
  16. Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma
    Munmee Dutta, Hidewaki Nakagawa, Hiroaki Kato, Kazuhiro Maejima, Shota Sasagawa, Kaoru Nakano, Aya Sasaki-Oku, Akihiro Fujimoto, Raúl Nicolás Mateos, Ashwini Patil et al. · 2020 · PeerJ
  17. Parkin: A targetable linchpin in human malignancies
    Ahmad Perwez, Khushnuma Wahabi, M. Moshahid A. Rizvi · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  18. Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells
    Tsukasa Tanida, Masahiro Tanemura, Eiji Miyoshi, Hiroaki Nagano, Kenta Furukawa, YUJI NONAKA, Hirofumi Akita, Naoki Hama, Hiroshi Wada, Koichi Kawamoto et al. · 2014 · International Journal of Oncology
  19. Carcinosarcoma of the pancreas: comprehensive clinicopathological and molecular characterization
    Jin Li, Tao Wei, Jian Zhang, Shumei Wei, Qi Chen, Bryan Wei Chen, Yue Zhou, Liang Wen, Hao Qin, Xueli Bai et al. · 2020 · HPB
  20. Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression
    S. J. Kim, Susana García‐Recio, Chad J. Creighton, Charles M. Perou, Jeffrey M. Rosen · 2019 · Oncogene
  21. Genomics screens for metastasis genes
    Jinchun Yan, Qihong Huang · 2012 · Cancer and Metastasis Reviews
  22. Delineating the longitudinal tumor evolution using organoid models
    Zhaolian Lu, Beina Nie, Weiwei Zhai, Zheng Hu · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
  23. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3
    Jun Zou, Xuanzeng Pei, Dan Xing, Xiaojun Wu, Shuai Chen · 2021 · Journal of Cellular and Molecular Medicine
  24. Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
    Ricarda Hinzpeter, Seyed Ali Mirshahvalad, Roshini Kulanthaivelu, Claudia Ortega, Ur Metser, Zhihui A. Liu, Elena C. Elimova, Rebecca K.S. Wong, Jonathan C. Yeung, Raymond Woo-Jun Jang et al. · 2022 · Cancers
  25. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer
    Sung Woo Ko, Seung Bae Yoon · 2023 · World Journal of Gastrointestinal Oncology
  26. Mutational topography reflects clinical neuroblastoma heterogeneity
    Elias Rodríguez-Fos, Mercè Planas-Fèlix, Martin Burkert, Montserrat Puiggròs, Joern Toedling, Nina Thiessen, Eric Blanc, Annabell Szymansky, Falk Hertwig, Naveed Ishaque et al. · 2023 · Cell Genomics
  27. Double-strand breaks induce inverted duplication chromosome rearrangements by a DNA polymerase δ-dependent mechanism
    Amr Al-Zain, Mattie R. Nester, Iffat Ahmed, Lorraine S. Symington · 2023 · Nature Communications
  28. ReConPlot: an R package for the visualization and interpretation of genomic rearrangements
    Jose Espejo Valle-Inclán, Isidro Cortés‐Ciriano · 2023 · Bioinformatics
  29. Response to “The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory” DOI: 10.1002/bies.201100025
    David Lawrence Vaux · 2011 · BioEssays
  30. The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancer
    David Jérémie Birnbaum, Émilie Mamessier, Daniel Birnbaum · 2012 · Cell Cycle
  31. Pancreatic cancer genomics: where can the science take us?
    J.S. Graham, Nigel Balfour Jamieson, R. Rulach, Sean Michael Grimmond, David Kuang-Fu Chang, Andrew Victor Biankin · 2014 · Clinical Genetics
  32. Targeting the tumour profile using broad spectrum chimaeric antigen receptor T-cells
    Shoba A. Navai, Nabil M. Ahmed · 2016 · Biochemical Society Transactions
  33. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC)
    C.I. Edvard Smith · 2016 · Seminars in Cancer Biology
  34. Photoacoustic Imaging for Cancer Diagnosis and Therapy Guidance
    Yun‐Sheng Chen, Doug Yeager, Stanislav Emelianov · 2014 · Elsevier eBooks
  35. Reviving the Autopsy for Modern Cancer Evolution Research
    Tamsin J. Robb, Rexson Datquen Tse, Cherie Blenkiron · 2021 · Cancers
  36. Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
    Yolanda Rodrı́guez Gil, Paula Jiménez Sánchez, Raúl Muñoz Velasco, Ana García García, Victor Javier Sanchez-Arevalo Lobo · 2021 · International Journal of Molecular Sciences
  37. P53 long noncoding RNA regulatory network in cancer development
    Aravindhan Surendar, Laith Ali Younus, Methaq Hadi Lafta, Alexander Anatolyevich Markov, Yulianna Ivanovna Enina, N Yushchenko, Lakshmi Prasanth Thangavelu, Seyed Mojtaba Mostafavi, Michail V. Pokrovskii, Majid Ahmadi · 2021 · Cell Biology International
  38. Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought
    Antonio Agostini, Arturo Orlacchio, Carmine Carbone, Ilaria Guerriero · 2022 · Frontiers in Immunology
  39. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples
    Miriam Redegalli, Greta Grassini, Gilda Magliacane, Lorenza Pecciarini, Marco Schiavo Lena, Chanel Elisha Smart, Rebecca L. Johnston, Nicola Waddell, Roberta Maestro, Marina Macchini et al. · 2022 · Clinical Gastroenterology and Hepatology
  40. Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis
    Miyuki Suguro, Noriaki Yoshida, Akira Umino, Harumi Kato, Hiroyuki Tagawa, Masao Nakagawa, Noriko Fukuhara, Sivasundaram Karnan, Ichiro Takeuchi, Toby Dylan Hocking et al. · 2014 · Cancer Science
  41. Triple Effect of Nonsense-Mediated mRNA Decay Inhibition as a Therapeutic Approach for Cancer
    Fabrice Lejeune · 2016 · Single Cell Biology
  42. Radiation therapy for oligometastatic non-small cell lung cancer
    Joseph Kamel Salama, Steven E. Schild · 2015 · Cancer and Metastasis Reviews
  43. mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival
    Ana-Bárbara García-García, M. Carmen Gómez-Mateo, Rebeca Hilario, Pilar Rentero-Garrido, Álvaro Martínez‐Doménech, Verónica González-Albert, Andrès M.R. Cervantes, Pablo Marín-García, Felipe Javier Chaves, Antonio Ferrández‐Izquierdo et al. · 2017 · Oncotarget
  44. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective
    Javier Perales-Patón, Elena Piñeiro-Yáñez, Héctor Tejero, Pedro Pablo Lopez-Casas, Manuel M. Hidalgo, Gonzalo Goméz-López, Fátima Al‐Shahrour · 2017 · Public Health Genomics
  45. A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis
    Hong Pan, Huanrong Diao, Wen Zhong, Taifang Wang, Ping Wen, Chunli Wu · 2021 · Frontiers in Oncology
  46. Primary cilia: a novel research approach to overcome anticancer drug resistance
    Kyung Ho Lee · 2023 · Frontiers in Molecular Biosciences
  47. Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors
    George Miles, James Michael Rae, Suresh S. Ramalingam, John D. Pfeifer · 2015 · Seminars in Oncology
  48. Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons
    Fei Yao, Pramila Nuwantha Ariyaratne, Axel M. Hillmer, Wah Heng Lee, Guoliang Li, Audrey S.M. Teo, Xing Yi Woo, Zhenshui Zhang, Jieqi P. Chen, Wan Ting Poh et al. · 2012 · PLoS ONE
  49. Clinicopathological Features of 15 Occult and 178 Clinical Pancreatic Ductal Adenocarcinomas in 8339 Autopsied Elderly Patients
    Yoko Matsuda, Toshiyuki Ishiwata, Shinichi Yachida, Akemi Suzuki, Yuri Hamashima, Hideki Hamayasu, Hisashi Yoshimura, Naoko Honma, Junko Aida, Kaiyo Takubo et al. · 2015 · Pancreas
  50. Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?
    Min Yuen Teo, Eileen Mary O'Reilly · 2016 · Journal of Gastrointestinal Oncology
  51. Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review
    T. Pavlidis, T. Pavlidis · 2017 · Journal of Investigative Surgery
  52. Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer
    Robert Słotwiński, Sylwia Małgorzata Słotwińska · 2017 · Central European Journal of Immunology
  53. The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease
    Hamza Alghamdi, Jennifer Dhont, Mohammad Krayem, Pauline De Bruyn, Benedikt Engels, Dirk Van Gestel, Robbe Van den Begin · 2022 · Cancers
  54. A Methodological Approach to Unravel Organ-Specific Breast Cancer Metastasis
    Sébastien Nola, Soraya Sin, Florian Bonin, Rosette Lidereau, Keltouma Driouch · 2012 · Journal of Mammary Gland Biology and Neoplasia
  55. FAM190A Rearrangements Provide a Multitude of Individualized Tumor Signatures and Neo-antigens in Cancer
    Francesca Scrimieri, Eric S. Calhoun, Kalpesh G. Patel, Rigu Gupta, David L. Huso, Ralph H. Hruban, Scott E. Kern · 2011 · Oncotarget
  56. Reconstructing Breakage Fusion Bridge Architectures Using Noisy Copy Numbers
    Shay Zakov, Vineet Bafna · 2015 · Journal of Computational Biology
  57. Metastasis as supra-cellular selection? A reply to Lean and Plutynski
    Pierre‐Luc Germain, Lucie Laplane · 2016 · Biology & Philosophy
  58. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
    Ashton Anthony Connor, Steve Gallinger · 2017 · Expert Review of Gastroenterology & Hepatology
  59. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset
    Jeffery Ho, Xiangchun Li, Lin Zhang, Yonghao Liang, Wei Hu, Johnny Chung Wai Yau, Hung Chan, Tony Gin, Matthew T.V. Chan, Gary Tse et al. · 2018 · Seminars in Cancer Biology
  60. Shrimp miRNA suppresses the stemness of human cancer stem cells via the PIN1 pathway
    Siyuan Zhang, Xiaobo Zhang · 2019 · The FASEB Journal
  61. A New Chromosome-Assigned Mongolian Gerbil Genome Allows Characterization of Complete Centromeres and a Fully Heterochromatic Chromosome
    Thomas D. Brekke, Alexander S. T. Papadopulos, Eva Julià, Òscar Fornas, Beiyuan Fu, Fengtang Yang, Roberto de la Fuente, Jesús Page, Tobias Baril, Alexander Hayward et al. · 2023 · Molecular Biology and Evolution
  62. Intraclonal Diversity in Follicular Lymphoma Analyzed by Quantitative Ultradeep Sequencing of Noncoding Regions
    Janice M. Spence, Andrew L. Abumoussa, John P Spence, Richard Burack · 2014 · The Journal of Immunology
  63. Emerging frontiers in pancreatic cancer research
    Chandan Kumar‐Sinha, Iris H. Wei, Diane M. Simeone · 2012 · Current Opinion in Gastroenterology
  64. Reconstructing tumor evolutionary histories and clone trees in polynomial-time with SubMARine
    Linda K. Sundermann, Jeff A. Wintersinger, Gunnar Rätsch, Jens Stoye, Quaid Morris · 2021 · PLoS Computational Biology
  65. Multi-ligand modified PC@DOX-PA/EGCG micelles effectively inhibit the growth of ER + , PR + or HER 2+ breast cancer
    Xiaozhen Wang, Jiecheng He, Siyuan Jiang, Yifei Gao, Lingkun Zhang, Liang Yin, Rong You, Yan‐Qing Guan · 2021 · Journal of Materials Chemistry B
  66. The Molecular Landscape of Pediatric Brain Tumors in the Next-Generation Sequencing Era
    Marlo R. Firme, Marco A. Marra · 2014 · Current Neurology and Neuroscience Reports
  67. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants
    Bhuwan Giri, Vrishketan Sethi, Vikas Dudeja, Sulagna Banerjee, Alan S. Livingstone, Ashok Kumar Saluja · 2017 · Current Opinion in Gastroenterology
  68. Mechanisms underlying genome instability mediated by formation of foldback inversions in Saccharomyces cerevisiae
    Bin-Zhong Li, Christopher D. Putnam, Richard David Kolodner · 2020 · eLife
  69. From Mutational Mechanisms in Single Cells to Mutational Patterns in Cancer Genomes
    Cheng‐Zhong Zhang, David S. Pellman · 2015 · Cold Spring Harbor Symposia on Quantitative Biology
  70. Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma
    Risky Oktriani, Anna Chiara Pirona, Lili Kalmár, Ariani Syafitri Rahadian, Beiping Miao, Andrea S. Bauer, Jörg D. Hoheisel, Michael Boettcher, Haoqi Du · 2024 · Cancers
  71. Having a direct look: Analysis of DNA damage and repair mechanisms by next generation sequencing
    Bettina Meier, Anton Gartner · 2014 · Experimental Cell Research
  72. A New Frontier in Personalized Cancer Therapy: Mapping Molecular Changes
    Katayoon Kasaian, Steven J.M. Jones · 2011 · Future Oncology
  73. MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma
    Zhenzhen Li, Jian Guo, Xiaolin Xu, Wenbin Wei, Junfang Xian · 2021 · British Journal of Radiology
  74. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values
    Suvina Amin, Seongjung Joo, Sandra Nolte, Hyun Kyoo Yoo, Nikunj Ramanikbhai Patel, Hilary F. Byrnes, Sara Costa-Cabral, Colin Johnson · 2022 · BMC Cancer
  75. Molecular portraits of lung cancer evolution
    Tikvah K. Hayes, Matthew M. Meyerson · 2023 · Nature
  76. Heterogeneity of c-Met expression in Chinese gastric cancer patients
    Chunchao Zhu, Jia Xu, M. Li, Gang Zhao, Hui Cao · 2015 · Human Pathology
  77. Epigenetics and blood disorders
    Bastian Scholz, Rolf Marschalek · 2012 · British Journal of Haematology
  78. Inhibition of APOBEC 3G activity impedes double‐stranded DNA repair
    Ponnandy Prabhu, Shivender M. D. Shandilya, Elena Britan‐Rosich, Adi Nagler, Celia A. Schiffer, Moshe Kotler · 2015 · FEBS Journal
  79. Instantaneous mutation rate in cancer initiation and progression
    Shuhao Sun, Fima C. Klebaner, Xinan Zhang, Tianhai Tian · 2018 · BMC Systems Biology
  80. Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
    Sang Myung Woo, Min Kyeong Kim, Boram Park, Eun‐Hae Cho, Tae-Rim Lee, Chang‐Seok Ki, Kyong‐Ah Yoon, Yun‐Hee Kim, Wonyoung Choi, Do Yei Kim et al. · 2021 · Cancers
  81. The “Achilles' Heel” of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies
    Kroopa Joshi, Benny Chain, Karl S. Peggs, Sergio A. Quezada · 2017 · Cold Spring Harbor Perspectives in Medicine
  82. Emerging trends and converging evidence in tumor evolution: A comprehensive review
    Chenqi Jin, Weiqi Li, Boqiang Liu, Lu-Qi Cao, Sven Marcel Stefan, Luoxi Yuan, Xin Yu, Liang Shi, Hong Yu · 2026 · Drug Resistance Updates
  83. Deciphering complex breakage-fusion-bridge genome rearrangements with Ambigram
    Chaohui Li, Lingxi Chen, Guangze Pan, Wenqian Zhang, Shuai Cheng Li · 2023 · Nature Communications
  84. Imaging Genomics and Multiomics: A Guide for Beginners Starting Radiomics-Based Research
    Shiva M. Singh, Bahram Mohajer, Shane A. Wells, Tushar Garg, Kate A Hanneman, Takashi Takahashi, Omran Aldandan, Morgan P. McBee, A. Jawahar · 2024 · Academic Radiology
  85. Science in Focus: Genomic Instability and its Implications for Clinical Cancer Care
    Saif S. Ahmad, Karim Ahmed, Ashok R. Venkitaraman · 2018 · Clinical Oncology
  86. Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer
    Alexandra Petersson, Natalie Andersson, Sofie Olsson Hau, Jakob Eberhard, Jenny Karlsson, Subhayan Chattopadhyay, Anders Valind, Jacob Elebro, Björn Nodin, Karin Leandersson et al. · 2022 · Molecular Cancer Research
  87. Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML
    Salvatore Nicola Bertuccio, Laura Anselmi, Riccardo Masetti, Annalisa Lonetti, Sara Cerasi, Sara Polidori, Salvatore Serravalle, Andrea Pession · 2021 · Cancers
  88. Identification of a Novel Subpopulation of Tumor-Initiating Cells from Gemcitabine-Resistant Pancreatic Ductal Adenocarcinoma Patients
    Kazuya Shimizu, Sachie Chiba, Yuichi Hori · 2013 · PLoS ONE
  89. Molecular and Genetic Basis of Pancreatic Carcinogenesis
    Vincent Bernard, Jason B. Fleming, Anirban Maitra · 2016 · Surgical Oncology Clinics of North America
  90. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies
    Hao Wang, Guihua Cui, Bo Yu, Meiyan Sun, Hong Yu Yang · 2020 · Current Pharmaceutical Design
  91. Correction: Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression
    S. J. Kim, Susana García‐Recio, Chad J. Creighton, Charles M. Perou, Jeffrey M. Rosen · 2019 · Oncogene
  92. Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures
    Jungsun Kim, Taelor J. Ekstrom, Wenli Yang, Greg Donahue, Dmytro Grygoryev, Thuy T. M. Ngo, John L. Muschler, Terry K. Morgan, Kenneth S. Zaret · 2021 · Molecular Cancer Research
  93. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma
    Xiaoying Li, Wanting Hou, Chaoxin Xiao, Heqi Yang, Chengjian Zhao, Dan Cao · 2024 · Cellular Oncology
  94. Validation of a Microfluidic Device Prototype for Cancer Detection and Identification: Circulating Tumor Cells Classification Based on Cell Trajectory Analysis Leveraging Cell‐Based Modeling and Machine Learning
    Rifat Rejuan, Eugenio Aulisa, Wei Li, Travis Thompson, Sanjoy Kumar, Sunčica Čanić, Yifan Wang · 2025 · International Journal for Numerical Methods in Biomedical Engineering
  95. Primary and metastatic cellular landscapes in human pancreatic cancer
    Nina G. Steele, Veerin R. Sirihorachai, Ahmed M. Elhossiny, Ian M. Loveless, Padma Kadiyala, Monica E. Bonilla, Emily L. Lasse Opsahl, Carinna Solano Vargas, Katelyn L. Donahue, Samantha B. Kemp et al. · 2025 · iScience
  96. Implications of Targeted Genomic Disruption of β-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells
    Petter Angell Olsen, Nina Therese Solberg, Kaja Lund, Tore Sandnes Vehus, Monika Gelazauskaite, Steven Ray Wilson, Stefan Johannes Karl Krauss · 2014 · PLoS ONE
  97. Investigating the role of functional imaging in the management of soft-tissue sarcomas of the extremities
    Martin Vallières, Monica F. Serban, Ibtissam Benzyane, Zaki Ahmed, Shu Xing, Issam El Naqa, Ives R. Levesque, Jan P. Seuntjens, Carolyn R Freeman · 2018 · Physics and Imaging in Radiation Oncology
  98. Cell-morphodynamic phenotype classification with application to cancer metastasis using cell magnetorotation and machine-learning
    Remy Elbez, Jeff Folz, Alan M. McLean, Hernan Roca, Joseph M. Labuz, Kenneth J. Pienta, Shuichi Takayama, Raoul Kopelman · 2021 · PLoS ONE
  99. Predictive value of radiomics-based machine learning for the disease-free survival in breast cancer: a systematic review and meta-analysis
    Dongmei Lu, Yuke Yan, Min Jiang, Shaoqin Sun, Haifeng Jiang, Yashan Lu, Wenwen Zhang, Xing Zhou · 2023 · Frontiers in Oncology
  100. New Approaches to the Treatment of Pancreatic Cancer
    Maeve Aine Lowery, Eileen Mary O'Reilly · 2011 · BioDrugs